Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...

The acute SBI rate was 0.07 during the 12-month study period, which met the predefined success rate of less than 1 acute SBI per patient per year. The Food and Drug Administration (FDA) has approved ...

The study offers one of the most detailed maps yet of how human antibody responses vary from person to person.

Read more about Nanoparticle and AI-driven vaccines target broad protection against emerging threats on Devdiscourse ...